Gerald L. Ray & Associates’s UnitedHealth UNH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
– Sell
-56,095
Closed -$11M – 253
2017
Q3
$11M Sell
56,095
-175
-0.3% -$33.8K 1.37% 14
2017
Q2
$10.4M Sell
56,270
-950
-2% -$167K 1.35% 13
2017
Q1
$9.38M Sell
57,220
-380
-0.7% -$62.2K 1.28% 16
2016
Q4
$9.22M Sell
57,600
-269
-0.5% -$40.2K 1.34% 16
2016
Q3
$8.1M Buy
57,869
+74
+0.1% +$10.4K 1.22% 17
2016
Q2
$8.16M Sell
57,795
-2,200
-4% -$293K 1.3% 17
2016
Q1
$7.73M Hold
59,995
– – 1.25% 18
2015
Q4
$7.06M Sell
59,995
-425
-0.7% -$49.7K 1.12% 21
2015
Q3
$7.01M Buy
60,420
+75
+0.1% +$8.98K 1.17% 17
2015
Q2
$7.36M Buy
60,345
+400
+0.7% +$47.3K 1.12% 18
2015
Q1
$7.09M Sell
59,945
-150
-0.2% -$16.7K 1.07% 20
2014
Q4
$6.08M Sell
60,095
-250
-0.4% -$23.7K 0.93% 29
2014
Q3
$5.2M Sell
60,345
-1,000
-2% -$84.5K 0.85% 35
2014
Q2
$5.02M Hold
61,345
– – 0.85% 33
2014
Q1
$5.03M Sell
61,345
-300
-0.5% -$22.6K 0.91% 32
2013
Q4
$4.64M Buy
61,645
+1,100
+2% +$79K 0.87% 33
2013
Q3
$4.34M Sell
60,545
-100
-0.2% -$7.16K 0.9% 32
2013
Q2
$3.97M Hold
60,645
– – 0.89% 34

Other funds holding UNH

Gerald L. Ray & Associates's UNH Position: Q2 2018 in Review

Gerald L. Ray & Associates sold out of UnitedHealth (UNH) in Q2 2018, closing a stake of 56,095 shares — an estimated $11M sold.

Gerald L. Ray & Associates first reported a position in UNH in Q2 2013 and held it in 18 quarters. The position peaked at $11M in Q3 2017. 1,751 funds tracked by Wall St. Rank hold UNH as of Q2 2018.

  • Gerald L. Ray & Associates reported no remaining UnitedHealth position as of Q2 2018 after selling out during the quarter.
  • Gerald L. Ray & Associates sold 56,095 UnitedHealth shares in Q2 2018, an estimated $11M.
  • Gerald L. Ray & Associates first reported a position in UnitedHealth in Q2 2013 and held it in 18 quarters.
  • Gerald L. Ray & Associates's UnitedHealth position peaked at $11M in Q3 2017.
  • 1,751 funds tracked by Wall St. Rank held UnitedHealth as of Q2 2018.

Based on Gerald L. Ray & Associates's 13F filing for Q2 2018.